5 results found.

Hyponatremia Clinical Trial using Tolvaptan; Placebo; Hepatic Encephalopathy Assessment; Quality of Life Assessment; Vital signs; Blood laboratory tests; Ascites Evaluation; Edema

New York University School of Medicine - Recruiting 18 years or older.
- Tolvaptan to Reduce Length of Stay in Hospitalized Patients With Cirrhosis and Hyponatremia.
Tolvaptan; Placebo; Hepatic Encephalopathy Assessment; Quality of Life Assessment; Vital signs; Blood laboratory tests; Ascites Evaluation; Edema

Hyponatremia Clinical Trial using Conivaptan hydrochloride; Placebo

Astellas Pharma Inc - Recruiting 2 years to 17 years.
- A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multi-Center, Dose-Titration Study to Assess the Efficacy, Safety and Pharmacokinetics of Intravenous Conivaptan (Vaprisolr) in Pediatric Subjects With Euvolemic or Hypervolemic Hyponatremia.
Conivaptan hydrochloride; Placebo

Hyponatremia Clinical Trial

Karolinska University Hospital - Recruiting 18 years to 48 years.
- Will Reduction in Plasma Sodium Reduce Myometrium Contractility in Humans? An Invitro Study of Pregnant Myometrium at Term..

Hyponatremia and Extracellular Fluid in Cirrhotic Clinical Trial using Tolvaptan; Placebo

Korea Otsuka Pharmaceutical Co.,Ltd. - Recruiting 20 years or older.
- Effect of Samsca on Control of Hyponatremia and Extracellular Fluid in Cirrhotic Patients With Ascites.
Tolvaptan; Placebo

Heart Failure, or Hyponatremia Clinical Trial using Fluid restriction

Rigshospitalet, Denmark - Recruiting 18 years or older.
- The Significance of the Vasopressin System of the Hemodynamics, Water Balance and Prognosis in Chronic Heart Failure.
Fluid restriction